Market Overview

Q4 Earnings Preview For American Eagle Outfitters


American Eagle Outfitters (NYSE: AEO) announces its next round of earnings this Wednesday, Mar. 6. Here is Benzinga's everything-that-matters guide for the Q4 earnings announcement.

Earnings and Revenue

Wall Street expects EPS of 42 cents and sales around $1.26 billion.

The current analyst consensus estimate would represent a 4.55 percent decline in the company's EPS figure. Revenue would be up 2.52 percent on a year-over-year basis. Here's how the company's reported EPS has stacked up against analyst estimates in the past:


Quarter Q3 2018 Q2 2018 Q1 2018 Q4 2017
EPS Estimate 0.48 0.31 0.22 0.44
EPS Actual 0.48 0.34 0.23 0.44

Stock Performance

For a full 12 months, the return has risen by 0.44 percent. Given that these returns are generally positive, long-term shareholders are probably relaxed going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.

Analysts have adjusted their estimates lower for EPS and revenues over the past 90 days. Analysts generally rate American Eagle Outfitters stock as Neutral. The strength of this rating has maintained conviction over the past three months.

Conference Call

American Eagle Outfitters is scheduled to hold a conference call at 4:00 p.m. ET and it can be accessed here.

Posted-In: Earnings News


Related Articles (AEO)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Craft Brew Alliance Q4 Earnings Preview

The Daily Biotech Pulse: Horizon Pharma Under DoJ Radar, FDA Greenlights J&J's Depression Drug, Endologix Reverse Split